EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1

Vladimir Petrovic, Vladislav A Malkov, Andrew N Billin, Uptal D Patel, Pablo E Pergola, Glenn M Chertow, Jan Skupien, Andrzej S Krolewski

Kidney Research and Clinical Practice · 28.10.2026 · 45 (6) · 933-939

DOI: 10.23876/j.krcp.25.198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, erschienen am 28.10.2026. Verfasst von Vladimir Petrovic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Biosciences, Foster City, CA, USA. vladimir.petrovic@gilead.com. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concentration of circulating soluble tumor necrosis factor receptor 1 is associated with faster progression in patients with diabetic kidney disease based on data obtained from large longitudinal cohort studies. A cutpoint of 4.3 ng/mL baseline plasma concentration was identified to stratify patients and predict clinical outcome. We set out to test the prognostic utility of this cutpoint in a randomized clinical trial.

Methods

Soluble tumor necrosis factor receptor 1 concentration was measured across plasma samples from Joslin cohort and selonsertib trial cohort. Estimated glomerular filtration rate slope was calculated using a patient-specific linear regression model based on serum creatinine concentration and compared between the cohorts. Kidney-related events were plotted using Kaplan–Meier estimates for both cohorts.

Results

Participants from both the clinical study cohort and the observational cohort showed an inverse relationship between baseline plasma concentrations of tumor necrosis factor receptor 1 and estimated glomerular filtration rate. When stratified based on baseline soluble tumor necrosis factor receptor 1 cutpoint, higher probability of experiencing a clinical event was found in patients with levels of soluble tumor necrosis factor receptor 1 exceeding 4.3 ng/mL in either of the cohorts.

Conclusion

We demonstrated the prognostic utility of plasma concentrations of circulating soluble tumor necrosis factor receptor 1 in identifying individuals with diabetic kidney disease at an elevated risk of progressive kidney function decline in a randomized clinical study setting. This data supports previous findings from large observational cohorts and supports the use of this marker as a reliable predictor of disease outcome.

Schlagwörter

Stichwörter der Autor:innen

Diabetic kidney diseaseEnd-stage kidney diseaseGlomerular filtration rateSelonsertibType 2 diabetes mellitus

Autor:innen und Institutionen

  • Gilead Biosciences, Foster City, CA, USA. vladimir.petrovic@gilead.com.
  • Gilead Biosciences, Foster City, CA, USA.
  • Department of Medicine, Duke University, Durham, NC, USA.
  • Renal Associates PA, San Antonio, TX, USA.
  • Departments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
  • Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA, USA.

Förderung

  • Gilead Sciences Inc.

Zitieren

APA

Petrovic, V., Malkov, V. A., Billin, A. N., Patel, U. D., Pergola, P. E., Chertow, G. M., Skupien, J., & Krolewski, A. S. (2026). Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1. Kidney Research and Clinical Practice, 45(6), 933-939. https://doi.org/10.23876/j.krcp.25.198

Vancouver

Petrovic V, Malkov VA, Billin AN, Patel UD, Pergola PE, Chertow GM, et al. Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1. Kidney Research and Clinical Practice. 2026;45(6):933-939. doi:10.23876/j.krcp.25.198

BibTeX
@article{Petrovic2026,
  author = {Petrovic, Vladimir and Malkov, Vladislav A and Billin, Andrew N and Patel, Uptal D and Pergola, Pablo E and Chertow, Glenn M and Skupien, Jan and Krolewski, Andrzej S},
  title = {Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1},
  journal = {Kidney Research and Clinical Practice},
  year = {2026},
  volume = {45},
  number = {6},
  pages = {933--939},
  doi = {10.23876/j.krcp.25.198}
}
Kostenlos starten →